Biological outcomes in disease-modification trials

被引：0
|
作者：
Galasko, D [1 ]
机构：
[1] UCSD, Dept Neurosci, San Diego, CA USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
37
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [31] Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
    Vissers, Maurits F. J. M.
    Heuberger, Jules A. A. C.
    Groeneveld, Geert Jan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 33
  • [32] Challenges in detecting disease modification in Parkinson's disease clinical trials
    Athauda, Dilan
    Foltynie, Thomas
    PARKINSONISM & RELATED DISORDERS, 2016, 32 : 1 - 11
  • [33] Early intervention in Crohn's disease: towards disease modification trials
    Danese, Silvio
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    GUT, 2017, 66 (12) : 2179 - 2187
  • [34] Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma
    Scadding, G. K.
    McDonald, M.
    Backer, V.
    Scadding, G.
    Bernal-Sprekelsen, M.
    Conti, D. M.
    De Corso, E.
    Diamant, Z.
    Gray, C.
    Hopkins, C.
    Jesenak, M.
    Johansen, P.
    Kappen, J.
    Mullol, J.
    Price, D.
    Quirce, S.
    Reitsma, S.
    Salmi, S.
    Senior, B.
    Thyssen, J. P.
    Wahn, U.
    Hellings, P. W.
    FRONTIERS IN ALLERGY, 2024, 4
  • [35] Behavioral outcomes in clinical trials for Alzheimer disease
    Ferris, SH
    Mackell, JA
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : S10 - S15
  • [36] The outcomes of Perthes' disease DEVELOPMENT OF A CORE OUTCOMES SET FOR CLINICAL TRIALS IN PERTHES' DISEASE
    Leo, D. G.
    Jones, H.
    Murphy, R.
    Leong, J. W.
    Gambling, T.
    Long, A. F.
    Laine, J.
    Perry, D. C.
    BONE & JOINT JOURNAL, 2020, 102B (05): : 611 - 617
  • [37] Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy
    Iori, Valentina
    Iyer, Anand M.
    Ravizza, Teresa
    Beltrame, Luca
    Paracchini, Lara
    Marchini, Sergio
    Cerovic, Milica
    Hill, Cameron
    Ferrari, Mariella
    Zucchetti, Massimo
    Molteni, Monica
    Rossetti, Carlo
    Brambilla, Riccardo
    White, H. Steve
    D'Incalci, Maurizio
    Aronica, Eleonora
    Vezzani, Annamaria
    NEUROBIOLOGY OF DISEASE, 2017, 99 : 12 - 23
  • [38] Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
    Hung, Albert Y.
    Schwarzschild, Michael A.
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1393 - 1405
  • [39] Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned
    Albert Y. Hung
    Michael A. Schwarzschild
    Neurotherapeutics, 2020, 17 : 1393 - 1405
  • [40] Biomarkers for disease modification trials - The innovative medicines initiative and AddNeuroMed
    Lovestone, S.
    Francis, P.
    Strandgaard, K.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 359 - 361
12345